Science Foundation Arizona Announces $10 Million in Grants to Fund Research Collaboration With Industry Science Foundation Arizona (SFAz), through its Strategic Research Group (SRG) program, today announced that it is granting nearly
C-Path Makes Progress to Safely Speed Medical Discoveries to Market William Mattes of C-Path spoke at the Arizona Pavillion May 8th 2007 about the Predictive Safety Testing Consortium.
The Predictive Safety Testing Consortium enables companies to share and validate safety biomarkers. To address the issues surrounding a decade-long decrease in the number of new drug approvals, the U.S. Food and Drug Administratio
Pharmaceutical Companies and FDA Making Strides Developing a new drug is a costly and time-intensive venture. It often takes years to safely develop, test, and ultimately gain Fo
C-Path Adopts Rosetta Resolver® System for the PSTC Rosetta Biosoftware announced today that The Critical Path Institute (C-Path) adopted the Rosetta Resolver® system for C-PathR
Raymond Woosley, M.D., Ph.D., Provides Expert Testimony in Congressional Hearings President and CEO of The Critical Path Institute (C-Path) provided testimony and answered questions about drug development yesterd
Tucson Nonprofit Seeks to Get Cures to Patients Faster A little-noticed 2004 report from the Food and Drug Administration contained a bombshell. Although spending on research and develo
New Corporate Members and Leaders for C-Path’s Predictive Safety Testing Consortium Announced The Critical Path Institute (C-Path) today announced seven new members that have recently joined the Predictive Safety Testing Con
C-Path Receives $675,000.00 Award for FDA Collaboration The Critical Path Institute (C-Path) has received $675,000 from the US Food and Drug Administration (FDA) for the first year of wh
Valley Fever Cure a Step Closer The federal government is backing the first potential cure for valley fever, a serious lung disease that has spiked in recent year